Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.

Pancholi P, Liu Q, Tricoche N, Zhang P, Perkus ME, Prince AM.

J Infect Dis. 2000 Jul;182(1):18-27. Epub 2000 Jun 29.

PMID:
10882577
2.

Host-range restriction of vaccinia virus E3L-specific deletion mutants.

Beattie E, Kauffman EB, Martinez H, Perkus ME, Jacobs BL, Paoletti E, Tartaglia J.

Virus Genes. 1996;12(1):89-94.

PMID:
8879125
3.

Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.

Perkus ME, Tartaglia J, Paoletti E.

J Leukoc Biol. 1995 Jul;58(1):1-13. Review.

PMID:
7616101
4.

Live attenuated vaccinia and other poxviruses as delivery systems: public health issues.

Perkus ME, Taylor J, Tartaglia J, Pincus S, Kauffman EB, Tine JA, Paoletti E.

Ann N Y Acad Sci. 1995 May 31;754:222-33. No abstract available.

PMID:
7625655
5.

Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

Beattie E, Denzler KL, Tartaglia J, Perkus ME, Paoletti E, Jacobs BL.

J Virol. 1995 Jan;69(1):499-505.

6.

Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.

Riviere M, Tartaglia J, Perkus ME, Norton EK, Bongermino CM, Lacoste F, Duret C, Desmettre P, Paoletti E.

J Virol. 1992 Jun;66(6):3424-34.

7.

NYVAC: a highly attenuated strain of vaccinia virus.

Tartaglia J, Perkus ME, Taylor J, Norton EK, Audonnet JC, Cox WI, Davis SW, van der Hoeven J, Meignier B, Riviere M, et al.

Virology. 1992 May;188(1):217-32.

PMID:
1566575
8.

Vaccinia virus encodes a protein with similarity to glutaredoxins.

Johnson GP, Goebel SJ, Perkus ME, Davis SW, Winslow JP, Paoletti E.

Virology. 1991 Mar;181(1):378-81.

PMID:
1994586
9.

Deletion of 55 open reading frames from the termini of vaccinia virus.

Perkus ME, Goebel SJ, Davis SW, Johnson GP, Norton EK, Paoletti E.

Virology. 1991 Jan;180(1):406-10.

PMID:
1984660
10.

The complete DNA sequence of vaccinia virus.

Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, Paoletti E.

Virology. 1990 Nov;179(1):247-66, 517-63.

PMID:
2219722
11.

Vaccinia virus host range genes.

Perkus ME, Goebel SJ, Davis SW, Johnson GP, Limbach K, Norton EK, Paoletti E.

Virology. 1990 Nov;179(1):276-86.

PMID:
2171207
12.

Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.

Guo PX, Goebel S, Perkus ME, Taylor J, Norton E, Allen G, Languet B, Desmettre P, Paoletti E.

J Virol. 1990 May;64(5):2399-406.

13.

Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Guo PX, Goebel S, Davis S, Perkus ME, Languet B, Desmettre P, Allen G, Paoletti E.

J Virol. 1989 Oct;63(10):4189-98.

14.
15.
16.

Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.

Evans LA, Thomson-Honnebier G, Steimer K, Paoletti E, Perkus ME, Hollander H, Levy JA.

AIDS. 1989 May;3(5):273-6.

PMID:
2548535
17.
18.

Expression of herpes simplex virus glycoprotein D on antigen presenting cells infected with vaccinia recombinants and protective immunity.

Wachsman M, Aurelian L, Hunter JC, Perkus ME, Paoletti E.

Biosci Rep. 1988 Aug;8(4):323-34.

PMID:
3263886
19.

Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.

Wachsman M, Aurelian L, Smith CC, Lipinskas BR, Perkus ME, Paoletti E.

J Infect Dis. 1987 Jun;155(6):1188-97.

PMID:
3033094
20.

Vaccinia virus as an expression vector.

Piccini A, Perkus ME, Paoletti E.

Methods Enzymol. 1987;153:545-63. No abstract available.

PMID:
2828850
21.

Insertion and deletion mutants of vaccinia virus.

Perkus ME, Panicali D, Mercer S, Paoletti E.

Virology. 1986 Jul 30;152(2):285-97.

PMID:
3014720
23.

Recombinant vaccinia virus: immunization against multiple pathogens.

Perkus ME, Piccini A, Lipinskas BR, Paoletti E.

Science. 1985 Sep 6;229(4717):981-4.

PMID:
2992092
24.

Live recombinant vaccines using genetically engineered vaccinia virus.

Paoletti E, Perkus ME, Piccini A.

Antiviral Res. 1985;Suppl 1:301-7. No abstract available.

PMID:
3866514
25.

Wasting waste.

Perkus ME, Lieb M.

Science. 1970 Oct 16;170(3955):262-3. No abstract available.

PMID:
5460029

Supplemental Content

Loading ...
Support Center